Importantly, molecular depletion of IGFBP2 expression using siRNA suppressed cell proliferation, enhanced cell death, decreased migration and invasion in LAM patient-derived TSC2-null cells. This evidence concerns the gene IGFBP2 and lymphangioleiomyomatosis.